Sue Brennan is the Director of the Melbourne GRADE Centre and a Senior Research Fellow at Cochrane Australia, in the School of Public Health and Preventive Medicine, Monash University. Her field of expertise is systematic review and guideline methodology, with a focus on evidence-informed decision-making in public health where contributions include leading reviews for national guidelines on lower risk alcohol consumption and infection control. Through leadership roles in the international GRADE working group and Cochrane, she works with researchers, national policy-makers and guideline developers to implement best practice methods in evidence synthesis and guideline development. She has trained more than 1000 participants in GRADE and systematic review methodology, is an author of four core chapters in the Cochrane Handbook, and co-author of the PRISMA, PRIOR and SWIM reporting guidelines.

Jun is a healthcare researcher with over 17 years of experience in evidence-based medicine. She is the Director of Nottingham Ningbo GRADE Centre at the University of Nottingham Ningbo (China), and lead for systematic review and clinical practice guidelines at the University of Nottingham (UK). The scope of her expertise spans across primary research and secondary synthesis. Her strength lies particularly in establishing national and international platform, promotes research collaboration and knowledge exchange. Born and raised in north China, educated in the UK, she has a keen interest in improving standards of care in LMIC and resource-limited settings. She is the founding member of China Clinical Practice Guideline Alliance (GUIDANCE) - the first and largest national platform for evidence-based guideline production in China. Jun has been an active reviewer/editor for Cochrane Collaboration since 2005, working across culture, continents, and stakeholders to promote evidence-based practice, particularly in guideline development and implementation. Besides those research activities, she enjoys teaching and knowledge sharing with other users in science community. Her teaching video has over 200,000 viewings on Youtube.

Dr. Yngve Falck-Ytter is Professor of Medicine at Case Western Reserve University, Cleveland and Chief, Gastroenterology and Hepatology, VA Northeast Ohio Health Care System. His research interest focuses on clinical trials as well as research methodology and evidence translation. He has previously held appointments as Associate Director at the German Cochrane Center and Institute for Biostatistics at the University of Freiburg, Germany. He is an AGA Fellow, previous chair of the AGA’s Clinical Guideline Committee, and recipient of the AGA’s Outstanding Service Award for rapid guidance during the COVID-19 pandemic in 2021. Additionally, he has been a member of the GRADE working group since 2002 and a GRADE guideline methodology consultant to numerous national and international organizations for over 20 years. He has been co-chairing internationally recognized guidelines, such as from the IDSA, the American Gastroenterology Association, the American College of Chest Physicians, and the World Health Organization. Dr. Falck-Ytter is a founding member of the U.S. GRADE Network and the Evidence Foundation.

Elie Akl is a tenured Professor of Medicine at the American university of Beirut (AUB). He serves as the Associate Dean for Clinical Research at the Faculty of Medicine, leads the division of General Internal Medicine and Geriatrics (GIMG) at AUB Medical Center, directs the AUB GRADE Center, and co-directs the Center for systematic reviews of health policy and systems research (SPARK). His research expertise is in systematic reviews, practice guidelines, and conflicts of interest. He serves as a guideline methodologist for a number of leading professional organizations and the World Health Organization. He published close to 500 peer-reviewed papers and was listed by Thomson Reuters as one of the 2015 "world’s most influential scientific minds" and as one of the “Highly Cited Researchers” yearly since 2015.

Dr Mouna Jameleddine is the Director of the Health Technology Assessment (HTA) department at the Tunisian agency (INEAS). She is playing the leading role in HTA institutionalization in Tunisia including the development of guidelines and policies. Dr Jameleddine has worked in different environments for over 15 years. She collaborated in 2014, within the cabinet of the Minister of Health, on defining policies related to health technologies. Within INEAS, Dr. Jameleddine gained practical experience in evaluating technologies, that she shared conducting capacity building activities for authorities and universities in Tunisia and other emerging countries. She is active in many international networks; She was elected in 2018 as a member of the INAHTA board and serves since 2021 as INAHTA Vice President. She is also acting as the co-chair of GINAHTA and as the chair of ISPOR HTA roundtable for Middle East and Africa. She is member of several WHO global experts groups such as HTA and benefit packages, cost effectiveness data across settings and 2021 pricing policies’ TAG. Moreover, she contributed to several WHO guidelines.

Tamara Kredo is a medical doctor and specialist in clinical pharmacology and holds the position of Deputy Director and Chief Specialist Scientist at Cochrane South Africa, South African Medical Research Council. She is an Associate Professor Extraordinary at Stellenbosch University in both the Department of Medicine (clinical pharmacology) and Department of Global Health (epidemiology and biostatistics) and an Honorary Associate Professor at the University of Cape Town’s, School of Public Health and Family Medicine. She works in the field of evidence-based healthcare practice and training, rational therapeutics, and clinical practice guidelines. Her research explores the methods, quality and content of clinical practice guidelines in southern Africa. She is involved in conducting reviews on Essential Medicines including COVID-19 treatments and vaccines informing national guidelines for the South African Department of Health. She holds several leadership roles including co-directing Cochrane Africa, and co-lead of the South African GRADE Network, and was previously Chair of the Organizing Committee for the inaugural Global Evidence Summit in 2017. She has been on a number of strategic and advisory committees including being a member of the South African National Essential Medicines List Committee, and Vaccines Ministerial Advisory Committee for Covid-19. In 2020 she was elected as a Board member to Cochrane’s Governing Board.

Paul is the Director for the Centre for Guidelines at NICE and member of NICE’s executive team and board. He has been with NICE since 2009, where he was responsible for setting up the Institute’s accreditation programme for guideline developers. This programme evaluated the quality of processes used by organisations that developed guidelines, and awarded an accreditation mark to those achieving the required standard. The aim was to raise the quality of guideline production. Before joining NICE, Paul spent over 20 years in international medical publishing and communications, focusing on evidence to aid healthcare decision making and therapeutics. Now based in Manchester in the UK, during his career Paul has lived, worked and travelled internationally as part of his role. Paul is a member of the Royal Pharmaceutical Society and has a postgraduate diploma in publishing studies.

Ivan Florez is Pediatrician, with a Master in Clinical Epidemiology, and a Ph.D. in Health Research Methodology from McMaster University. He is an Associate Professor at the Department of Pediatrics at the University of Antioquia (Medellin, Colombia), Pediatrician in the Pediatric Intensive Care Unit at Clinica Las Americas-AUNA, Medellin, Colombia, and Assistant Professor (Part-Time) at McMaster University (Canada). He is a former Deputy Director of Clinical Practice Guidelines (CPG) for the Health Technology Assessment Agency of Colombia (IETS). Dr. Ivan Florez is the current Leader of the AGREE Collaboration, is an Academic/Associate Editor for Systematic Reviews and PlosONE journals, and the Director of Cochrane Colombia. He is also member of the Cochrane's Conflicts of Interests panel. His research has focused on CPG (development and implementation methods), Knowledge Synthesis (Systematic reviews and Network Meta-analysis), Pediatrics, and Childhood Gastroenteritis. Dr. Florez has participated in the development and implementation of many Clinical Practice Guidelines in Colombia, Latin America and North America. He has co-authored more than 100 journal articles in international journals and more than 20 book chapters about pediatrics, clinical epidemiology, clinical practice guidelines, and evidence synthesis.

Patrick is a medical officer, researcher, and district medical officer in Cameroon. He also is the team lead at eBASE Africa. He is active across the evidence ecosystem with a focus on evidence implementation in health and education. Patrick is active within global evidence communities including Africa Evidence Network, Cochrane, Campbell, JBI, GIN, and COVID-19 Recmaps. At eBASE his team seeks to improve livelihoods through innovations and best practice and especially for underserved populations. The team is innovating African storytelling approach for mobilizing research evidence uptake for households, practitioners, and policymakers through pilot projects funded by Ambassade de France au Cameroun and Grand Challenges Canada. His team is using this approach in prevention and mitigation of COVID-19 and sexual and gender-based violence including in conflict settings. As part of the globalization of the storytelling approach, eBASE team will be giving a training and the GIN Conference in Toronto in September 2022.

Dr. Susan D. Moffatt-Bruce, joined the Royal College of Physicians and Surgeons of Canada as Chief Executive Officer in January 2020. She is also the interim Chief Executive Officer of Royal College International. Dr. Moffatt-Bruce is an academic leader and surgeon, with sharp business acumen and a passion for value-driven care. Prior to the Royal College, Dr. Moffatt-Bruce served as executive director at The Ohio State University (OSU) Wexner Medical Center University Hospital. As the OSU Wexner Medical Center’s inaugural chief quality and patient safety officer, she led data analysis, transparent reporting of outcomes and process improvement for a seven-hospital academic medical center. Dr. Moffatt-Bruce and her team were celebrated for their success in developing and implementing a learning healthcare system across the patient care continuum. A funded health outcomes research scientist and surgeon, Dr. Moffatt-Bruce is a lifelong learner and has used her skills to help develop curriculum for residents and faculty around quality and outcomes research as the educational enablement of learning healthcare systems. She is now a faculty member of the Department of Surgery and Professor at the University of Ottawa, where she is committed to enabling learning cycles, resulting in value-based care.

Dr Miloslav Klugar, is Director and founder of the Czech National Centre for Evidence-Based Healthcare and Knowledge translation and its three pillars which are Cochrane Czech Republic, The Czech Republic EBHC centre; JBI centre of Excellence and Masaryk University GRADE Centre. He is also adjunct Associate Professor of Public Health, at Faculty of Health and Medical Sciences, University of Adelaide, Australia. Miloslav is focused on the development, implementation, advocacy and teaching of Evidence-Based Healthcare, especially on the evidence synthesis and clinical practice guidelines. He is a member of several international method groups of Joanna Briggs Institute, GRADE Working Group, Cochrane and Guidelines International Network. As a member of JBI GRADE centre, Miloslav focused on the implementation and improvement of GRADE methods within systematic reviews and clinical practice guidelines. Miloslav is authorised representative of Czech Health Research Council at Guidelines International Network, and he is also Head methodologist within the project of Czech Health Research Council, Ministry of Health of the Czech Republic and Institute of Health Information and Statistics of the Czech Republic with name “Clinical Practice Guidelines”.